ACB.TO - Aurora Cannabis Inc.

Toronto - Toronto Real Time Price. Currency in CAD
0.7300
+0.0100 (+1.39%)
At close: 04:00PM EDT
Stock chart is not supported by your current browser
Previous Close0.7200
Open0.7400
Bid0.7300 x 0
Ask0.7400 x 0
Day's Range0.7200 - 0.7400
52 Week Range0.7200 - 2.4900
Volume230,648
Avg. Volume668,153
Market Cap248.921M
Beta (5Y Monthly)3.00
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    Aurora Expands Medical Cannabis Portfolio in Germany: New flower varieties for patients with high THC needs

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and a leading manufacturer and supplier of dried flower for medical patients worldwide, today announced the expansion of its portfolio in Germany with the launch of two new cannabis flower products for patients. Pedanios 27/1 FRG CA and Pedanios 29/1 SRD CA are dried cannabis flower with high tetrahydrocannabinol (THC) content. With these new therapeutic options now avai

  • CNW Group

    Aurora Cannabis Partners with Strainprint to Empower Patients on their Cannabis Journey

    Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced the launch of a new tracking program designed to support and empower cannabis patients on their wellness journey.

  • CNW Group

    Aurora Introduces Fresh Innovation for Spring

    Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced a fresh lineup of innovative products. Coming soon to patients at Aurora Medical and to consumers at retail stores across the country, the company's expanded portfolio includes newly developed cultivars, strain-specific gummies and aromatic vapes. Flower products include two original strains from Occo, Aurora's esteemed breeding program: Pink Diesel '71 and Moon Berry.

  • CNW Group

    Aurora Repurchases ~$22 Million Principal Amount of Convertible Notes, Saving $1.2 Million in Annualized Interest Payments and Leaving ~$79 Million (US$59) of Notes Outstanding; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry

    Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has repurchased an aggregate of approximately $22.3 million (US$16.6 million) principal amount of its convertible senior notes ("Notes") in multiple transactions since the start of April 2023 at a total cash cost, including accrued interest, of $16.7 million (US$12.4 million) and $5.3 million (US$4.0 million), including accrued interest, satisfied

  • CNW Group

    Aurora and MedReleaf Australia Launch IndiMed Tempo 26, Further Strengthening Product Offerings for Medical Cannabis Patients

    Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and MedReleaf Australia today announced the launch of IndiMed Tempo 26, a range of new higher THC dried cannabis products for qualified patients under the MedReleaf Concession Scheme (MCS). Tempo 26 will add to the portfolio of products available, giving doctors the ability to prescribe from a wider range of options for medical cannabis patients.

  • CNW Group

    Aurora Repurchases ~$47 Million Principal Amount of Convertible Notes, Saving $2.6 Million in Annualized Interest Payments; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry

    Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has repurchased an aggregate of approximately $46.6 million (US$34.3 million) principal amount of its convertible senior notes ("Notes") at a total cost, including accrued interest, of $45.6 million (US$33.6 million) in cash, saving $2.6 million in annualized interest payments. Following completion of this repurchase, Aurora will have approximatel

  • CNW Group

    Aurora Provides Update on Nasdaq Listing

    Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced receipt of a notification letter (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") dated March 24, 2023, advising that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1) as the bid price of the Company's listed securities had closed at less than US$1.00 per share over the last 30 consecutive business days (the "Min

  • CNW Group

    Aurora Cannabis Announces Filing of Preliminary Base Shelf Prospectus

    Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced it has filed a new preliminary short form base shelf prospectus (the "Base Shelf Prospectus") with securities regulators in each of the provinces of Canada, except Quebec.

  • CNW Group

    Aurora Launches New Medical Flower Product, Valour - Designed for Veterans, by Veterans

    Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced the launch of Valour, a new cannabis cultivar designed for veterans, by veterans. Five per cent of net profits from the sale of Valour products will be used to support veteran organizations across Canada.

  • CNW Group

    Aurora and MedReleaf Australia Launch new Medical Cannabis Brand - CraftPlant

    Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and MedReleaf Australia today announced the launch of CraftPlant, a new medical cannabis brand for patients in the Australian market.

  • CNW Group

    Aurora Cannabis Announces Fiscal 2023 Second Quarter Results

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced its financial and operational results for the fiscal second quarter ended December 31, 2022. As a reminder, Fiscal 2023 is comprised of three quarters ending March 31, 2023.

  • CNW Group

    Aurora Cannabis to Host Second Quarter Fiscal Year 2023 Investor Conference Call

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2023 on Thursday, February 9, 2023 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the second quarter fiscal year 2023 after the close of markets that same day.

  • CNW Group

    Aurora Cannabis Announces Sale of Polaris Facility - Balance Sheet Remains Among Strongest in Industry

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that the Company has closed the sale of its Aurora Polaris facility for gross proceeds of approximately $15 million, previously announced to be closing under the Company's ongoing transformation program.

  • CNW Group

    Aurora's Greybeard Brand Wins KIND Magazine's 'Best Diamonds of the Year' Award

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is excited to announce its Greybeard Cannabis Co. brand has won KIND Magazine's 'Best Diamonds of the Year' award, as voted by hundreds of budtenders, store managers and independent cannabis retail owners across Canada.

  • CNW Group

    Aurora Cannabis Repurchases ~$103 Million Principal Amount of Convertible Notes; Balance Sheet Among Strongest in Industry

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that it has repurchased an aggregate of approximately $102.5 million (US$76.1 million) principal amount of its convertible senior notes ("Notes") at a total cost, including accrued interest, of $99.4 million (US$73.8 million) in cash. Following completion of this repurchase, Aurora will have approximately $148 million (US$110 million) of N

  • CNW Group

    High Tide Becomes Top Revenue-Generating Cannabis Company in Canada

    High Tide Inc. ("High Tide" or the "Company") (NASDAQ: HITI) (TSXV: HITI) (FSE: 2LYA), a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, announced today that according to new data recently released by the cannabis business publication, New Cannabis Ventures, the Company is now Canada's top revenue-generating cannabis company1.

  • CNW Group

    Aurora Cannabis Announces Results of 2022 Annual General and Special Meeting

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held today, Monday, November 14, 2022 by virtual webcast. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 92,937,078, representing 30.93% of Aurora's issued and outstanding common sh

  • CNW Group

    Aurora Cannabis Announces Fiscal 2023 First Quarter Results

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: AC) | (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the fiscal first quarter ended September 30, 2022. As a reminder, Fiscal 2023 will be comprised of three quarters, with the new fiscal year end being March 31, 2023.

  • CNW Group

    Aurora Cannabis to Host First Quarter Fiscal Year 2023 Investor Conference Call

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its first quarter fiscal year 2023 on Thursday, November 10, 2022 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the first quarter fiscal year 2023 after the close of markets that same day.

  • CNW Group

    Aurora Cannabis Announces Mailing of Management Information Circular for the Annual and Special Meeting of Shareholders

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to announce that the Company recently filed its management information circular (the "Circular") and related proxy materials (together with the Circular the "Meeting Materials") in advance of its annual and special meeting of shareholders (the "Meeting") scheduled for November 14, 2022.

  • CNW Group

    Aurora Announces Unprecedented Fall Product Release Across Adult-Use and Medical Markets

    Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a new and unprecedented fall lineup of cannabis products. New flower products include three unique and proprietary strains from Aurora's esteemed breeding program: Electric Honeydew, Ultra Grape Kush and Organic BC White Grape OG.

  • CNW Group

    Aurora Cannabis Repurchases ~US$23 Million Principal Amount of Convertible Notes; Balance Sheet Among Strongest in Industry

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that it has repurchased an aggregate of approximately $31.3 million (US$23.0 million) principal amount of its convertible senior notes ("Notes") at a total cost, including accrued interest, of $29.8 million (US$21.8 million) in cash.

  • CNW Group

    Aurora Cannabis Announces Fiscal 2022 Fourth Quarter and Full Year Results

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the fourth quarter and fiscal year ended June 30, 2022.

  • CNW Group

    S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index

    As a result of the quarterly review, S&P Dow Jones Indices will make the following changes in the S&P/TSX Composite Index and S&P/TSX 60 Index prior to the open of trading on Monday, September 19, 2022:

  • CNW Group

    Aurora Cannabis to Host Fourth Quarter and Full Fiscal Year 2022 Investor Conference Call and Related Year End Informational Filings

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and full fiscal year 2022 on Tuesday, September 20, 2022 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the fourth quarter and full fiscal year 2022 after the close of markets that same day.